Kezar Life Sciences (KZR) Receivables - Other (2023 - 2025)
Historic Receivables - Other for Kezar Life Sciences (KZR) over the last 3 years, with Q3 2025 value amounting to $1.7 million.
- Kezar Life Sciences' Receivables - Other rose 24820.0% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 24820.0%. This contributed to the annual value of $695000.0 for FY2023, which is N/A changed from last year.
- Kezar Life Sciences' Receivables - Other amounted to $1.7 million in Q3 2025, which was up 24820.0% from $1.7 million recorded in Q2 2025.
- Kezar Life Sciences' 5-year Receivables - Other high stood at $2.4 million for Q1 2024, and its period low was $500000.0 during Q3 2024.
- Over the past 3 years, Kezar Life Sciences' median Receivables - Other value was $1.7 million (recorded in 2025), while the average stood at $1.4 million.
- Data for Kezar Life Sciences' Receivables - Other shows a peak YoY increase of 24820.0% (in 2025) and a maximum YoY decrease of 2766.93% (in 2025) over the last 5 years.
- Kezar Life Sciences' Receivables - Other (Quarter) stood at $695000.0 in 2023, then fell by 28.06% to $500000.0 in 2024, then soared by 248.2% to $1.7 million in 2025.
- Its Receivables - Other stands at $1.7 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.7 million for Q1 2025.